• by bcarlson@marketresearch.com
  • November 26 2013
  • cloud


CMO Cites Kalorama Cloud Computing Numbers

CMO Cites Kalorama Cloud Computing Numbers

A recent issue of Australian-based CMO magazine, which focuses on management and technology, cited Kalorama’s growth numbers for cloud computing and our rationale that it is EMR driving the cloud market in healthcare.

According to Kalorama’s publisher, Bruce Carlson: “EMR [electronic medical records] is driving this market. Hospitals are building great systems for gathering electronic records, but they need solutions to store all of that data, and it can’t be a new server wing that might compe...

  • by esalazar@marketresearch.com
  • November 20 2013
  • hematology


A Complete Count of the Global Hematology Market

A Complete Count of the Global Hematology Market

Hematology testing stands far from the IVD market’s most ambitious clinical frontiers and, without significant expansion in clinical applications, is bound by gradual trends in patient population and available healthcare infrastructure (lab, physician, and other clinical clients). Lab industries in the developed world are largely undergoing consolidation and cost-cutting and resident patient populations are not growing fast enough - either in absolute numbers or testing intensity - to drive hema...

  • by bcarlson@marketresearch.com
  • November 19 2013
  • novartis


Grifols Boosts Presence in the Family Business, Blood IVD

Grifols Boosts Presence in the Family Business, Blood IVD

A large pharma/IVD concern, overextended into too many areas, has handed off a business unit to an experienced niche player. Novartis has sold it’s blood testing business to Spain-based Grifols, Inc. for 1.7 billion. The buyer is no stranger to the blood market. The company has a rich history dating to the development of plasmapheresis by Dr. Josep Antoni Grifols in 1951, and has continued to innovate. The company introduced NAT testing to detect hepatitis C (HCV) virus in plasma fractionation p...

  • by bcarlson@marketresearch.com
  • November 15 2013


Tablets Help Make EMR a Reality

Tablets Help Make EMR a Reality

Electronic medical records as a concept cannot happen unless data is entered in at the point of care. Enter tablet PCs to assist busy healthcare professionals enter data on the move. The global market for tablet PC devices in healthcare is expected to increase to $1.7 billion for 2013, reflecting an increase of nearly 27% over the prior year, according to a report we released this year. Several factors are driving the growth of this market including a shortage of qualified medical professionals,...

  • by bcarlson@marketresearch.com
  • November 11 2013


Proof Not Always Easy To Provide for IVD Tests

Proof Not Always Easy To Provide for IVD Tests

The key to a successful test product, one that will line up payors, is to establish the product’s effectiveness with clinical studies. But testing is not the same as treatment, it’s an area that’s a lot harder to prove with clinical data, according to our report on Reimubrsement for IVD Tests.

"Clinical trials pose unique challenges for diagnostic products. This is because there are typically several steps between the performance of a diagnostic test and a clinical outcome, and the ability of ...

  • by bcarlson@marketresearch.com
  • November 7 2013


Biomarkers Market Exceeds 25 Billion

Biomarkers Market Exceeds 25 Billion

“Biomarkers like CK-MB have many positive benefits to medicine,” said our analyst Melissa Elder in a recent press release. "Diseases are detected earlier, more effective treatments can be delivered, drug reactions reduced.” The biomarker market is valued at $25.9 billion for 2013, an increase of 10.2% since last year, according to Elder’s report. The Global Market for Biomarkers (Cancer Markers, Cardiac Markers, Blood Markers, Endocrine Markers, Infectious Disease and Neurological Disease Marker...

  • by bcarlson@marketresearch.com
  • November 5 2013
  • HIV


Spread of Infectious Disease Drives New Diagnostic Markets

Spread of Infectious Disease Drives New Diagnostic Markets

Increasing incidence of infectious disease is expected to make the market for infectious disease among the most dynamic in the in vitro diagnostics industry, according to Kalorama Information. The world market for infectious disease tests is estimated at $14.5 billion in 2012 and should grow at a slightly higher rate than the rest of the diagnostics market. The finding was made in our new report, The World Market for Infectious Disease Diagnostic Tests.

“Unfortunately for world populations, th...